E-Cigarettes, Harm Reduction, and Tobacco Control: A Path Forward?

TY - JOUR

T1 - E-Cigarettes, Harm Reduction, and Tobacco Control

T2 - A Path Forward?

AU - Glynn, Thomas J.

AU - Hays, J. Taylor

AU - Kemper, Katherine

N1 - Funding Information: Potential Competing Interests: Dr Glynn has received expenses and honoraria from Pfizer, Inc., to participate in an advisory committee meeting and has participated as an Executive Committee member of Global Bridges, an initiative supported by Pfizer Inc. , through an unrestricted education grant to Mayo Clinic . Dr Hays has served as Medical Director of Global Bridges, an initiative supported by Pfizer Inc. , through an unrestricted education grant to Mayo Clinic . Ms Kemper serves as Executive Director of Global Bridges, an initiative supported by Pfizer Inc. , through an unrestricted education grant to Mayo Clinic .

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85099796504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099796504&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2020.11.022

DO - 10.1016/j.mayocp.2020.11.022

M3 - Short survey

C2 - 33494956

AN - SCOPUS:85099796504

SN - 0025-6196

VL - 96

SP - 856

EP - 862

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 4

ER -